STAT News
US · 2 hrs ago
STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment
STAT is live-blogging a meeting of FDA experts to review Replimune’s experimental melanoma drug, RP1.
Do you trust STAT News?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!